# WO2025106572A1 **Entity class:** Published patent application **Priority date:** November 14, 2023 **Filing date:** November 13, 2024 **Publication date:** May 22, 2025 **Collection:** [[collections/Neurotech|Neurotech]] **Canonical source articles:** [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] · [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] ## Definition **WO2025106572A1** is the published patent application in the E11-associated family covering compositions and methods for analyzing cells in mammalian tissue. The record describes fusion proteins bearing distinguishable peptide epitopes and iterative detection methods relevant to PRISM's protein-barcode architecture. The listed inventors are [[wiki/Andrew C. Payne|Andrew C. Payne]], [[wiki/Kathleen G. C. Leeper|Kathleen G. C. Leeper]], [[wiki/Sven Truckenbrodt|Sven Truckenbrodt]], [[wiki/Sung Yun Park|Sung Yun Park]], [[wiki/Sam Rodriques|Samuel G. Rodriques]], and [[wiki/Julia M. Michalska|Julia M. Michalska]]. The listed assignee is E11 Bio LLC. The assignee's legal name does not by itself determine or contradict E11's publicly stated nonprofit FRO status. ## Relationships - **Intellectual-property relationship:** [[wiki/PRISM (E11 Bio)|PRISM (E11 Bio)]] molecular architecture. - **Assignee:** E11 Bio LLC; linked organizational context: [[wiki/E11 Bio|E11 Bio]]. - **Role boundary:** patent inventorship, paper authorship, scientific advising, and organizational control are distinct predicates. - **Collection route:** [[collections/Neurotech|Neurotech]]. ## Sources - [Google Patents — WO2025106572A1](https://patents.google.com/patent/WO2025106572A1/en)